Press releases
Press releases dating back to 2018 are available below. Search them by keyword or browse by year/business category.
Press releases for other local operating companies can be viewed on the local websites.
-
GSK Partners with Save the Children to Address Mental Health Concerns of Children Affected by Cat Lake Crisis in Northern Ontario
GSK Partners with Save the Children to Address Mental Health Concerns of Children Affected by Cat Lake Crisis in Northern Ontario
Read more -
Two new options for self-administration of NUCALA now approved in Canada making it the first anti-IL5 biologic to offer patients with severe eosinophilic asthma a choice of how and where to receive treatment
NUCALA (mepolizumab) has been approved in Canada in two new formats
Read more -
Many Canadian Adults Acknowledge the Importance of Immunization Yet Are Not Getting Vaccinated
Many Canadian Adults Acknowledge the Importance of Immunization Yet Are Not Getting Vaccinated
Read more -
Local employee selected for charity mountain climb
Local employee selected for charity mountain climb
Read more -
New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration
New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration
Read more -
GSK statement on vaccine shortages
GSK statement on vaccine shortages
Read more -
GSK’s Mississauga manufacturing operations undergoes $36 M modernization
GSK’s Mississauga manufacturing operations undergoes $36 M modernization
Read more -
National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up
National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up
Read more -
GSK and NEOMED call for proposals for innovative early stage human therapeutic projects in Quebec
GSK and NEOMED call for proposals for innovative early stage human therapeutic projects in Quebec
Read more -
Quebec’s Committee on Immunization (CIQ) recommends preferential use of SHINGRIX for the prevention of shingles in adults aged 50 and up
Quebec’s Committee on Immunization (CIQ) recommends preferential use of SHINGRIX for the prevention of shingles in adults aged 50 and up
Read more -
TRELEGY ELLIPTA approved in Canada as the first single inhaler triple therapy for the treatment of appropriate patients with COPD
TRELEGY ELLIPTA approved in Canada as the first single inhaler triple therapy for the treatment of appropriate patients with COPD
Read more -
GSK Statement: GSK Voluntary Recall of VENTOLIN DISKUS Lot 786G in Canada
GSK Statement: GSK Voluntary Recall of VENTOLIN DISKUS Lot 786G in Canada
Read more
Find out more about us
-
About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
-
Products
We make a wide range of prescription medicines and prescribed vaccines
-
Research & development
Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products.
-
Careers
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
